AB InBev jumps after Q1 results beat expectations, volume growth returns

Anheuser-Busch InBev (BUD) is up 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The stock appears to be moving higher after the company posted a strong Q1 2026 earnings update that topped expectations and showed a return to organic volume growth. Investors also seemed to respond positively to improving mix (premium and no-alcohol) and management’s reiterated FY26 EBITDA growth outlook.

Details:

AB InBev reported Q1 2026 organic revenue growth of 5.8%, with total volumes up 0.8% and beer volumes up 1.2%, contrasting with market fears of continued volume declines.

Profitability improved, with normalized EBITDA up 5.3% and underlying EPS rising to $0.97, supported by higher revenue, cost discipline, and mix.

The company maintained its FY26 outlook for EBITDA growth in line with its medium-term target range of 4% to 8%.

AB InBev also disclosed progress on its $6 billion share buyback program (with $1.4 billion completed as of May 1, 2026), which can add support to per-share metrics.

Sources:

SEC (EDGAR), AB InBev Investor Relations, MarketScreener, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BUD Hedge Fund Activity

We have seen 255 institutional investors add shares of $BUD stock to their portfolio, and 237 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 3,760,808 shares (-93.9%) from their portfolio in Q4 2025, for an estimated $240,842,144
DODGE & COX removed 3,432,790 shares (-9.4%) from their portfolio in Q4 2025, for an estimated $219,835,871
FMR LLC removed 2,940,975 shares (-55.6%) from their portfolio in Q4 2025, for an estimated $188,340,039
GQG PARTNERS LLC added 2,338,805 shares (+inf%) to their portfolio in Q4 2025, for an estimated $149,777,072
BANK OF MONTREAL /CAN/ removed 1,140,383 shares (-95.9%) from their portfolio in Q4 2025, for an estimated $73,030,127
HOLOCENE ADVISORS, LP added 1,039,934 shares (+inf%) to their portfolio in Q4 2025, for an estimated $66,597,373
MORGAN STANLEY added 966,378 shares (+29.8%) to their portfolio in Q4 2025, for an estimated $61,886,847

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$BUD Analyst Ratings

Wall Street analysts have issued reports on $BUD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a "Overweight" rating on 11/19/2025

To track analyst ratings and price targets for $BUD, check out Quiver Quantitative's $BUD forecast page.

$BUD Price Targets

Multiple analysts have issued price targets for $BUD recently. We have seen 3 analysts offer price targets for $BUD in the last 6 months, with a median target of $88.0.

Here are some recent targets:

Robert Ottenstein from Evercore ISI Group set a target price of $100.0 on 02/13/2026
Chris Carey from Wells Fargo set a target price of $88.0 on 02/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.